Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Sitting less could be a lifeline for frail hearts – a new trial tests a simple program

NCT ID NCT07762898

Disease control Sponsor: Gansu University of Chinese Medicine Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This trial tests a 1-month nurse-led program designed to help older adults with coronary heart disease and frailty reduce their daily sitting time. Participants are randomly assigned to either the program or a control group, and the program uses education, goal setting, self-monitoring, and social support to encourage more movement. The study will measure changes in sedentary time and other health outcomes over a 3-month period, including a 2-month follow-up. The goal is to see if this practical approach can improve physical activity and health management in this vulnerable population.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A 1-month nurse-delivered behavioral program based on the Integrated Theory of Health Behavior Change, including health education, goal setting, self-monitoring, action planning, feedback, and social support to reduce sedentary behavior.
What this could lead to
If effective, this program could offer a practical, low-cost way to help older adults with heart disease and frailty sit less and become more active, potentially improving their overall health and quality of life.
What could go wrong
This is a small, early-stage feasibility study, so results may not be conclusive or widely applicable. The program relies on self-reported behavior and participant motivation, which can be unreliable, and the 1-month intervention may be too short to produce lasting changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 64 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 60 years or older. * Diagnosis of stable coronary artery disease according to the Chinese Primary -Care Guideline for Stable Coronary Artery Disease (2020). * Canadian Cardiovascular Society (CCS) angina class I or II. * Fried Frailty Phenotype score of 1 or higher, including participants with pre-frailty (score 1-2) or frailty (score 3-5). * Total sedentary time of 6 hours or more per day. * The participant or the participant's primary caregiver is able to use the WeChat application. * Able and willing to provide informed consent and voluntarily participate in the study. Exclusion Criteria: * Currently participating in another research study. * Presence of a malignant tumor. * Presence of a severe infectious disease. * Presence of a physical impairment that substantially limits limb mobility. * Presence of a language impairment that prevents effective communication or -completion of study assessments. * Presence of cognitive impairment that prevents understanding of study procedures or completion of study assessments.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Coronary artery disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

coronary artery disorder Motor Activity Sedentary Behavior

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Coronary artery disease Prefrailty Sedentary behavior

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Affiliated Hospital of Gansu University of Chinese Medicine

    Lanzhou, Gansu, 730000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.